Tumoren des Urogenitaltraktes

  • D. E. Johnson
  • D. A. Swanson
  • A. C. von Eschenbach

Zusammenfassung

Neoplasmen der Prostata, der Blase und der Nieren zählen zu den häufigsten Tumoren, die den menschlichen Körper betreffen. Sie sind oft symptomarm, so daß die Diagnose erst zu einem sehr späten Zeitpunkt möglich ist. Hodentumoren sind sehr bösartig und treten vorwiegend bei jungen Männern auf. Neoplasmen der Harnleiter, der Harnröhre, des Penis, des Skrotums, des Nebenhodens und der Samenblasen sind selten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Gutartige Tumoren des Nierenparenchyms

  1. Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Fascicle 12 of: Atlas of Tumor Pathology, 2nd series. Armed Forces Institute of Pathology, 1975Google Scholar
  2. Bissada NK et al: Tuberous sclerosis complex and renal angiomyolipoma. Urology 1975; 6:105PubMedCrossRefGoogle Scholar
  3. Dennis RL et al: Juxtaglomerular cell tumor of the kidney. J Urol 1985; 134:334PubMedGoogle Scholar
  4. Dunnick NR et al: The radiology of juxtaglomerular tumors. Radiology 1983; 147:321PubMedGoogle Scholar
  5. Farrow GM et al: Renal angiomyolipoma: A clinical pathological study of 32 patients. Cancer 1968; 22:564PubMedCrossRefGoogle Scholar
  6. Jardin A et al: Diagnosis and treatment of renal angiomyolipoma (based on 15 cases): Arguments in favor of conservative surgery (based 8 cases). Eur Urol 1980; 6:69PubMedGoogle Scholar
  7. Oesterling JE et al: Management of renal angiomyolipoma. J Urol 1986; 135:1121PubMedGoogle Scholar
  8. Shapiro RA et al: Renal tumors associated with tuberous sclerosis: The case for aggressive surgical management. J Urol 1984; 132:1170PubMedGoogle Scholar
  9. Squires JP et al: Juxtaglomerular cell tumor of the kidney. Cancer 1984; 53:516PubMedCrossRefGoogle Scholar
  10. Zerhouni EA et al: Management of bleeding renal angio-myolipomas by transcatheter embolization following CT diagnosis. Urol Radiol 1984; 6:205.PubMedCrossRefGoogle Scholar

Adenokarzinom der Niere

  1. Almgard LE et al: Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation. Br J Urol 1973; 45:474PubMedCrossRefGoogle Scholar
  2. Altaffer LF III, Chenault OEW Jr, Paraneoplastic endo-crinopathies associated with renal tumors. J Urol 1979; 122:573PubMedGoogle Scholar
  3. Babaian RJ, Swanson DA: Serum haptoglobin: A nonspecific tumor marker for renal cell carcinoma. South Med J 1982; 75:145CrossRefGoogle Scholar
  4. Balfe DM et al: Evaluation of renal masses considered in-determinant on computed tomography. Radiology 1982; 142:421PubMedGoogle Scholar
  5. Bander NH: Comparison of antigen expression of human renal cancers in vivo and in vitro. Cancer 1984; 53:1235PubMedCrossRefGoogle Scholar
  6. Barnes CA, Beckman EN: Renal oncocytoma and its congeners. Am J Clin Pathol 1983; 79–312Google Scholar
  7. Beahrs OH, Myers MH (editors): Manual for Staging Cancer, 2nd ed. Lippincott, 1983Google Scholar
  8. Bell ET: Renal Diseases, 2nd ed. Lea & Febiger, 1950Google Scholar
  9. Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975Google Scholar
  10. Bennington JL, Kradjian RM: Renal Carcinoma. Saunders, 1967Google Scholar
  11. Bennington JL, Laubscher FA: Epidemiologic studies on carcinoma of the kidney. 1. Association of renal adenocarcinoma with smoking. Cancer 1968; 21:1069PubMedCrossRefGoogle Scholar
  12. Bloom HJG: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973; 32:1066PubMedCrossRefGoogle Scholar
  13. Bowers TA et al: Bone metastases from renal carcinoma: The preoperative use of transcatheter arterial occlusion. J Bone Joint Surg (Am) 1982; 64:749Google Scholar
  14. Boxer RJ et al: Renal carcinoma: Computer analysis of 96 patients treated by nephrectomy. J Urol 1979; 122:598PubMedGoogle Scholar
  15. Bracken RB et al: Secondary renal neoplasms: An autopsy study. South Med J 1979; 72:806PubMedCrossRefGoogle Scholar
  16. Brereton HD et al: Indomethacin-responsive hypercalcemia in a patient with a renal cell carcinoma. N Engl J Med 1974; 291:83PubMedCrossRefGoogle Scholar
  17. Bush WH Jr, Burnett LL, Gibbons RP: Needle tract seeding of renal cell carcinoma. AJR 1977; 129:725PubMedGoogle Scholar
  18. Cherrie RJ et al: Prognostic implications of vena caval extension of renal cell carcinoma. J Urol 1982; 128:910PubMedGoogle Scholar
  19. Cho C, Friedland GW, Swenson RS: Acquired renal cystic disease and renal neoplasms in hemodialysis patients. Urol Radiol 1984; 6:153PubMedCrossRefGoogle Scholar
  20. Chuang VP, Wallace S, Swanson DA: Technique and complications of renal carcinoma infarction. Urol Radiol 1981; 2:223PubMedCrossRefGoogle Scholar
  21. Chuang VP et al: Arterial occlusion in the management of pain from metastatic renal carcinoma. Radiology 1979; 133:611PubMedGoogle Scholar
  22. Cockett ATK: Lymphatic network of the kidney. 1. Anatomic and physiologic considerations. Urology 1977; 9:125PubMedCrossRefGoogle Scholar
  23. Cohen AJ et al: Hereditary renal cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301:592PubMedCrossRefGoogle Scholar
  24. Cronan JJ, Zeman RK, Rosenfield AT: Comparison of computed tomography, ultrasound, and angiography in staging renal cell carcinoma. J Urol 1982; 127:712PubMedGoogle Scholar
  25. Daniel WW Jr et al: Calcified renal masses: A review of ten years’ experience at the Mayo Clinic. Radiology 1972; 103:503PubMedGoogle Scholar
  26. deKernion JB: Lymphadenectomy for renal cell carcinoma. Urol Clin North Am 1980; 7:697PubMedGoogle Scholar
  27. deKernion JB, Berry D: The diagnosis and treatment of renal cell carcinoma. Cancer 1980; 44 (Suppl):1947Google Scholar
  28. deKernion JB, Ramming KP: The therapy of renal adenocarcinoma with immune RNA. Invest Urol 1980; 17:378PubMedGoogle Scholar
  29. deKernion JB et al: The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 1983; 130:1063PubMedGoogle Scholar
  30. Engelmann U et al: Digital subtraction angiography in staging renal cell carcinoma: Comparison with computerized tomography and histopathology. J Urol 1984; 132:1093PubMedGoogle Scholar
  31. Figlin RA et al: Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: A phase 1–11 trial. Cancer Treat Rep 1985; 69:263PubMedGoogle Scholar
  32. Finstad CL et al: Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci USA 1985; 85:2955Google Scholar
  33. Flocks RH, Kadesky MC: Malignant neoplasms of the kidney: An analysis of 353 patients followed 5 years or more. J Urol 1958; 79:196PubMedGoogle Scholar
  34. Fossa SD et al: Recombinant interferon a-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 1986; 57:1700PubMedCrossRefGoogle Scholar
  35. Freed SZ, Halperin JP, Gordon M: Idiopathic regression of metastases from renal cell carcinoma. J Urol 1977; 118:538PubMedGoogle Scholar
  36. Gibbons RP et al: Manifestations of renal cell carcinoma. Urology 1976; 8:201PubMedCrossRefGoogle Scholar
  37. Goldberg MF et al: Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemia. Am J Med 1964; 36:805PubMedCrossRefGoogle Scholar
  38. Golimbu M et al: Renal cell carcinoma: Survival and prognostic factors. Urology 1986; 27:291PubMedCrossRefGoogle Scholar
  39. Harris DT: Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol 1983; 10:422PubMedGoogle Scholar
  40. Hellekant C, Nyman CL: Routine celiac arteriography in patients with renal cell carcinoma. J Urol 1979; 122:17PubMedGoogle Scholar
  41. Heney NM, Nocks BN: The influence of perinephric fat involvement on survival in patients with renal cell carcinoma extending into the inferior vena cava. J Urol 1982; 128:18PubMedGoogle Scholar
  42. Hoehn W, Hermanek P: Invasion of veins in renal cell carcinoma: Frequency, correlation and prognosis. Eur Urol 1983; 9:276PubMedGoogle Scholar
  43. Holland JM: Cancer of the kidney: Natural history and staging. Cancer 1973; 32:1030PubMedCrossRefGoogle Scholar
  44. Hop WCJ, van der Werf-Messing BHP: Prognostic indexes for renal cell carcinoma. Eur J Cancer 1980; 16:833PubMedCrossRefGoogle Scholar
  45. Horn L, Horn HL: An immunological approach to the therapy of cancer. Lancet 1971; 2:466PubMedCrossRefGoogle Scholar
  46. Horton WA, Wong V, Eldridge R: Von Hippel-Lindau disease: Clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med 1976; 136:769PubMedCrossRefGoogle Scholar
  47. Hricak H et al: Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms. Radiology 1985; 154:709PubMedGoogle Scholar
  48. Hrushesky WJ, Murphy GP: Current status of the therapy of advanced renal carcinoma. J Surg Oncol 1977; 9:277PubMedCrossRefGoogle Scholar
  49. Hughson MD, Buchwald D, Fox M: Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986; 110:592PubMedGoogle Scholar
  50. Hulten L et al: Occurrence and localization in lymph node metastases in renal carcinoma. Scand J Urol Nephrol 1969; 3:129PubMedCrossRefGoogle Scholar
  51. Jacobs SC, Berg SI, Lawson RK: Synchronous bilateral renal cell carcinoma: Surgical excision. Cancer 1980; 46:2341Google Scholar
  52. Johnson DE, von Eschenbach AC, Sternberg J: Bilateral renal cell carcinoma. J Urol 1978; 119:23PubMedGoogle Scholar
  53. Kato T et al: Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C.J Urol 1981; 125:19PubMedGoogle Scholar
  54. Kearney GP et al: Results of inferior vena cava resection for renal cell carcinoma. J Urol 1981; 125:769PubMedGoogle Scholar
  55. Kirkman H: Estrogen-induced tumors of the kidney. Natl Cancer Inst Monogr 1959; 1:1PubMedGoogle Scholar
  56. Klein MJ, Valensi QJ: Proximal tubular adenocarcinoma of the kidney with so-called oncocytic features: A clinical pathologic study of 13 cases of a rarely reported neoplasm. Cancer 1976; 38:906PubMedCrossRefGoogle Scholar
  57. Krane RJ et al: Removal of renal cell carcinoma extending into the right atrium using cardiopulmonary bypass, profound hypothermia and circulatory arrest. J Urol 1984; 131:945PubMedGoogle Scholar
  58. Krown SE et al: Treatment of advanced renal cell carcinoma (RCC) with recombinant leukocyte A interferon (rIFN-A). (Abstract) Am Soc Clin Oncol 1983; 2:58Google Scholar
  59. Lang ED: Arteriography in the diagnosis and staging of hypernephromas. Cancer 1973; 32:1043PubMedCrossRefGoogle Scholar
  60. Lang EK: Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma. Cancer 1984; 54:2205Google Scholar
  61. Lang EK, Sullivan J, deKernion JB: Work in progress: Transcatheter embolization of renal cell carcinoma with radioactive infarct particles. Radiology 1983; 147:413PubMedGoogle Scholar
  62. Levine E et al: CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients. AJR 1984; 142:125PubMedGoogle Scholar
  63. Lieber MM, Tornera KM, Farrow GM: Renal oncocytoma. J Urol 1981; 125:481PubMedGoogle Scholar
  64. Lieber MM et al: Renal adenocarcinoma in young adults: Survival and variables affecting prognosis. J Urol 1981; 125:164PubMedGoogle Scholar
  65. Ljungberg B et al: Prognostic significance of DNA content in renal cell carcinoma. J Urol 1986; 135:422PubMedGoogle Scholar
  66. Lytton B, Rosof B, Evans JS: Parathyroid hormone-like activity in a renal carcinoma producing hypercalcemia. J Urol 1965; 93:127PubMedGoogle Scholar
  67. Maldazys JD, deKernion JB: Prognostic factors in metastatic renal carcinoma. J Urol 1986; 136:376PubMedGoogle Scholar
  68. Malek RS, Utz DC, Culp OS: Hypernephroma in the solitary kidney: Experience with 20 cases and review of the literature. J Urol 1976; 116:553PubMedGoogle Scholar
  69. Marshall FF, Reitz BA, Diamond DA: A new technique for management of renal cell carcinoma involving the right atrium: Hypothermia and cardiac arrest. J Urol 1984; 131:103PubMedGoogle Scholar
  70. McCune CS, Schapira DV, Henshaw EC: Specific immunotherapy of advanced renal carcinoma: Evidence for the polyclonality of metastases. Cancer 1981; 47:1984Google Scholar
  71. McDonald JR, Priestly JT: Malignant tumors of the kidney: Surgical and prognostic significance of tumor thrombosis of the renal vein. Surg Gynecol Obstet 1943; 77:295Google Scholar
  72. McDonald MW: Current therapy for renal carcinoma. J Urol 1982; 127:211PubMedGoogle Scholar
  73. McNichols DW, Segura JW, DeWeerd JH: Renal cell carcinoma: Long-term survival and late recurrence. J Urol 1981; 126:17PubMedGoogle Scholar
  74. Morales A et al: Cytoreductive surgery and systemic bacille Calmette-Guérin therapy in metastatic renal cancer: A phase II trial. J Urol 1982; 127–230Google Scholar
  75. Morlock CG, Horton BT: Variations in systolic blood pressure in renal tumors: A study of 491 cases. Am J Med Sci 1936; 191:647Google Scholar
  76. Murphy JB, Marshall FF: Renal cyst versus tumor: A continuing dilemma. J Urol 1980; 123:566PubMedGoogle Scholar
  77. Neidhart JA: Interferon therapy for the treatment of renal cancer. Cancer 1986; 57 (8 Suppl): 1696PubMedCrossRefGoogle Scholar
  78. Neidhart JA et al: Active specific immunotherapy of stage IV renal carcinoma with aggregated tumor antigen adjuvant. Cancer 1980; 46:1128PubMedCrossRefGoogle Scholar
  79. Neidhart JA et al: Interferon-alpha therapy of renal cancer. Cancer Res 1984; 44:4140PubMedGoogle Scholar
  80. Novick AC et al: Partial nephrectomy in the treatment of renal adenocarcinoma. J Urol 1977; 118:932PubMedGoogle Scholar
  81. Novick AC et al: Surgical enucleation for renal cell carcinoma. J Urol 1986; 135:235PubMedGoogle Scholar
  82. Oberling C, Riviere M, Haguenau F: Ultrastructure of the clear cells in renal cell carcinoma and its importance for the demonstration of their renal origin. Nature 1960; 186:402PubMedCrossRefGoogle Scholar
  83. O’Dea MJ et al: The treatment of renal cell carcinoma with solitary metastasis. J Urol 1978; 120:540PubMedGoogle Scholar
  84. Otto U et al: Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol 1984; 132:237PubMedGoogle Scholar
  85. Parienty RA et al: Local recurrence after nephrectomy for primary renal cancer: Computerized tomography recognition. J Urol 1984; 132:246PubMedGoogle Scholar
  86. Petersson S et al: Diagnostic value of lipid content in cyst fluid. Pages 433–434 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors) A. R. Liss, 1982Google Scholar
  87. Petkovic S: Le stade anatomique dans l’appréciation du prognostique des tumeurs rénales. Urologia 1956; 23:125Google Scholar
  88. Petkovic S: The value of tumor tissue penetration into the renal veins and lymph nodes as an anatomical classification in kidney tumor prognostic parameters. Eur Urol 1980; 6:289PubMedGoogle Scholar
  89. Pritchett TR, Lieskovsky G, Skinner DG: Extension of renal cell carcinoma into vena cava: Clinical review and surgical approach. J Urol 1986; 135:460PubMedGoogle Scholar
  90. Quesada JR, Swanson DA, Guttermann JU: Phase II study of interferon alpha in metastatic renal-cell carcinoma: A progress report. J Clin Oncol 1985; 3:1086PubMedGoogle Scholar
  91. Quesada JR et al: Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 1985; 3:1522PubMedGoogle Scholar
  92. Riches EW, Griffiths IH, Thackray AC: New growths of the kidney and ureter. Br J Urol 1951; 23:297PubMedCrossRefGoogle Scholar
  93. Richie JP et al: Computerized tomography scan for diagnosis and staging of renal cell carcinoma. J Urol 1983; 129:1114PubMedGoogle Scholar
  94. Richie JP et al: Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid. J Urol 1984; 131:236PubMedGoogle Scholar
  95. Robey EL, Schellhammer PF: Adrenal gland and renal cell carcinoma: Is ipsilateral adrenalectomy a necessary component of radical nephrectomy? J Urol 1986; 135:453PubMedGoogle Scholar
  96. Robson CJ, Churchill B, Anderson W: Radical nephrectomy for renal cell carcinoma. J Urol 1969; 101:297PubMedGoogle Scholar
  97. Rosenberg SA et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485PubMedCrossRefGoogle Scholar
  98. Rouvière H: Anatomy of the Human Lymphatic System. Tobias MJ (translator) Edwards Brothers, 1938Google Scholar
  99. Schaner EG et al: Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: A prospective radiologic-pathologic study. AJR 1978; 131:51PubMedGoogle Scholar
  100. Spiessl B, Scheibe O, Wagner G (editors) TNM-Atlas: Illustrated Guide to the Classification of Malignant Tumors. Springer-Verlag, 1982Google Scholar
  101. Stauffer MH: Nephrogenic hepatosplenomegaly. Gastroenterology 1961; 40:694Google Scholar
  102. Sufrin G et al: Hormones in renal cancer. J Urol 1977; 117:433PubMedGoogle Scholar
  103. Swanson DA: Management of stage IV renal cancer. In: Principles and Management of Urologic Cancer, 2nd ed. Javadpour N (editor). Williams & Wilkins, 1983Google Scholar
  104. Swanson DA: Transabdominal radical nephrectomy. Pages 321–335 in: Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Johnson DE, Boileau MA (editors). Grune & Stratton, 1982Google Scholar
  105. Swanson DA, Bernardino ME: “Silent” osseous metastases in renal cell carcinoma: Value of CT. Urology 1982; 20:208PubMedCrossRefGoogle Scholar
  106. Swanson DA, Liles A: Bladder metastasis: A rare cause of hematuria in renal carcinoma. J Surg Oncol 1982; 20:80PubMedCrossRefGoogle Scholar
  107. Swanson DA et al: Angioinfarction and nephrectomy for metastatic renal cell carcinoma: An update. J Urol 1983; 130:449PubMedGoogle Scholar
  108. Swanson DA et al: Osseous metastases secondary to renal cell carcinoma. Urology 1981; 18:556PubMedCrossRefGoogle Scholar
  109. Tallberg T et al: Active specific immunotherapy with supportive measures in the treatment of palliatively ne-phrectomized, renal adenocarcinoma patients: A thirteen-year follow-up study. Eur Urol 1985; 11:233PubMedGoogle Scholar
  110. Topley M, Novick AC, Montie JE: Long-term results following partial nephrectomy for localized renal adenocarcinoma. J Urol 1984; 131:1050PubMedGoogle Scholar
  111. van der Werf-Messing B, van der Heul RO, Ledeboer RC: Renal cell carcinoma trial. Cancer Clin Trials 1978; 1:13Google Scholar
  112. Vickers M Jr: Serum haptoglobins: A preoperative detector of metastatic renal carcinoma. J Urol 1974; 112:310PubMedGoogle Scholar
  113. Wallace AC, Nairn RC: Renal tubular antigens in kidney tumors. Cancer 1972; 29:977PubMedCrossRefGoogle Scholar
  114. Warren MM, Kelalis PT, Utz DL: The changing concept of hypernephroma. J Urol 1970; 104:376PubMedGoogle Scholar
  115. Wehle MJ, Grabstald H: Contraindications to needle aspiration of solid renal mass: Tumor dissemination by renal needle aspiration. J Urol 1986; 136:446PubMedGoogle Scholar
  116. Williams RD, Hricak H: Magnetic resonance imaging in urology. J Urol 1984; 132:641PubMedGoogle Scholar
  117. Wynder EL, Mabuchi K, Whitmore WF Jr: Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 1974:53:16Google Scholar
  118. Zabbo A et al: Digital subtraction angiography for evaluating patients with renal carcinoma. J Urol 1985; 134:252PubMedGoogle Scholar
  119. Zincke H et al: Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantation. Mayo Clin Proc 1985; 60:651PubMedGoogle Scholar

Wilms-Tumor

  1. Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms’ tumor. Cancer 1978; 41:1937PubMedCrossRefGoogle Scholar
  2. Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975Google Scholar
  3. Bishop HC et al: Survival in bilateral Wilms’ tumor: Review of 30 National Wilms’ Tumor Study cases. J Pediatr Surg 1977; 12:631PubMedCrossRefGoogle Scholar
  4. Bolande RP, Brough AJ, Izant RJ Jr: Congenital meso-blastic nephroma of infancy: A report of 8 cases and the relationship to Wilms’ tumor. Pediatrics 1967:40:272PubMedGoogle Scholar
  5. Bove KE, McAdams AJ: The nephroblastomatosis complex and its relationship to Wilms’ tumor: A clinical pathologic treatise. Perspect Pediatr Pathol 1976; 3:185PubMedGoogle Scholar
  6. Bracken RB et al: Preoperative chemotherapy for Wilms’ tumor. Urology 1982; 19:55PubMedCrossRefGoogle Scholar
  7. Breslow NE, Beckwith JB: Epidemiological features of Wilms’ tumor: Results of the National Wilms’ Tumor Study. J Natl Cancer Inst 1982; 68:429PubMedGoogle Scholar
  8. Breslow NE et al: Prognosis for Wilms’ tumor patients with nonmetastatic disease of diagnosis: Results of the second National Wilms’ Tumor Study. J Clin Oncol 1985; 3:521PubMedGoogle Scholar
  9. Clouse JW et al: The changing management of Wilms’ tumor over a 30-year period: 1949–1978. Cancer 1985; 56:1484PubMedCrossRefGoogle Scholar
  10. D’Angio GJ et al: The treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Cancer 1976; 38:633PubMedCrossRefGoogle Scholar
  11. D’Angio GJ et al: The treatment of Wilms’ tumor: Results of the Second National Wilms’ Tumor Study. Cancer 1981; 47:2302Google Scholar
  12. D’Angio GJ et al: Wilms’ tumor: Genetic aspects and etiology: A report of the National Wilms’ Tumor Study (NWTS) Committee of the NWTS Group. Pages 43–57 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A.R.Liss, 1982Google Scholar
  13. D’Angio GJ et al: Wilms’ tumor: An update. Cancer 1980; 45:1791PubMedGoogle Scholar
  14. deKraker J et al: Preoperative chemotherapy in Wilms’ tumour: Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). Pages 131–194 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A. R. Liss, 1982Google Scholar
  15. Farewell VT et al: Retrospective validation of a new staging system for Wilms’ tumor. Cancer Clin Trials 1981; 4:167PubMedGoogle Scholar
  16. Hartman DS et al: Mesoblastic nephroma: Radiologic, pathologic correlation of 20 cases. AJR 1981; 136:69PubMedGoogle Scholar
  17. Jaffe N et al: Childhood urologic cancer therapy related sequelae and their impact on management. Cancer 1980; 45:1815PubMedGoogle Scholar
  18. Kay R, Tank E: Current management of bilateral Wilms tumor. J Urol 1986; 135:983PubMedGoogle Scholar
  19. Knudson Ag Jr, Strong LC: Mutation in cancer. A model for Wilms’ tumor of the kidney. J Natl Cancer Inst 1972; 48:313PubMedGoogle Scholar
  20. Leape LL: Diagnosis and management of Wilms’ tumor and neuroblastomas. Pages 179–199 in: Genitourinary Cancer. Skinner DG, deKernion JB (editors). Saunders, 1978Google Scholar
  21. Leape LL, Breslow NE, Bishop HC: The surgical treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Ann Surg 1978; 187:351PubMedCrossRefGoogle Scholar
  22. Lemierle J: The treatment of Wilms’ tumor in 1982: The status of the art. Pages 167–171 in: Renal Tumors: Proceedings of the First International Symposium on Kidney Tumors. Kuss R et al (editors). A.R.Liss, 1982Google Scholar
  23. Lemerle J et al: Effectiveness of preoperative chemotherapy in Wilms’ tumor: Results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1983; 1:604PubMedGoogle Scholar
  24. Lemerle J et al: Wilms’ tumor: Natural history and prognostic factors: A retrospective study of 248 cases treated at the Institute Gustave-Roussy 1952–1967. Cancer 1976; 36:2557Google Scholar
  25. Pendergrass TW: Congenital anomalies in children with Wilms’ tumor. Cancer 1976; 37:403PubMedCrossRefGoogle Scholar
  26. Rous SN et al: Nodular renal blastema, nephroblastomato-sis, and Wilms’ tumor: Different points on the same disease spectrum. Urology 1976; 8:599PubMedCrossRefGoogle Scholar
  27. Yunis JJ, Ramsay NKC: Familial occurrence of the aniridia-Wilms’ tumor syndrome with deletion 11. J Pediatr 1980; 96:1027PubMedCrossRefGoogle Scholar

Nierensarkom

  1. Bennington JL, Beckwith JB: Tumors of the Kidney, Renal Pelvis, and Ureter. Armed Forces Institute of Pathology, 1975Google Scholar
  2. Farrow GM et al: Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Cancer 1968; 22:545PubMedCrossRefGoogle Scholar
  3. Srinivas V et al: Sarcomas of the kidney. J Urol 1984; 132:13.PubMedGoogle Scholar

Nierenbeckentumoren

  1. Almgard LE et al: Thorotrast-induced renal tumors after retrograde pyelograms. Eur Urol 1977; 3:69PubMedGoogle Scholar
  2. Batata MA et al: Primary carcinoma of the ureter: A prognostic study. Cancer 1975; 35:1626PubMedCrossRefGoogle Scholar
  3. Boijsen E, Falin J: Angiography in carcinoma of the renal pelvis. Acta Radiol [Diagn] (Stockh) 1961; 56:81CrossRefGoogle Scholar
  4. Brookland RK, Richter MP: The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 1985; 133:952PubMedGoogle Scholar
  5. Grabstald H, Whitmore WF, Melamed MR: Renal pelvic tumors. JAMA 1971; 281:845CrossRefGoogle Scholar
  6. Johansson S, Wahlqvist L: A prognostic study of urothelial renal pelvic tumors: Comparison between the prognosis of patients treated with intrafascial nephrectomy and perifascial nephroureterectomy. Cancer 1979; 43:2525Google Scholar
  7. Melicow MM: Tumor of the urinary drainage tract: Urothelial tumors. J Urol 1945; 54:186Google Scholar
  8. Mitty HA, Baron MG, Fuler M: Infiltrating carcinoma of the renal pelvis: Angiographic features. Radiology 1969; 92:994PubMedGoogle Scholar
  9. Toppercer A: Fibroepithelial tumor of the renal pelvis. Can J Surg 1980; 23:269.PubMedGoogle Scholar

Harnleitertumoren

  1. Arger PH et al: Ultrasonic assessment of renal transitional cell carcinoma: Preliminary report. AJR 1979; 132:407PubMedGoogle Scholar
  2. Babaian RJ, Johnson DE, Chan RC: Combination nephroureterectomy and postoperative radiotherapy for infiltrative ureteral carcinomas. Int J Radiat Oncol Biol Phys 1980; 6:1229PubMedCrossRefGoogle Scholar
  3. Batata MA et al: Primary carcinoma of the ureter: A prognostic study. Cancer 1975; 35:1626PubMedCrossRefGoogle Scholar
  4. Gill WB, Lu CT, Bibbo M: Retrograde ureteral brushing. Urology 1978; 12:279PubMedCrossRefGoogle Scholar
  5. Huffman JL et al: Endoscopic diagnosis and treatment of upper-tract urothelial tumors: A preliminary report. Cancer 1985; 55:1422PubMedCrossRefGoogle Scholar
  6. Johnson DE, Babaian RJ: Conservative surgical management for noninvasive distal ureteral carcinoma. Urology 1979; 13:365PubMedCrossRefGoogle Scholar
  7. Kiriyama T, Hironaka H, Fukuda K: Six years of experience with retrograde biopsy of intraureteral carcinoma using the Dormia stone basket. J Urol 1976; 116:308PubMedGoogle Scholar
  8. Schmauz R, Cole P: Epidemiology of cancer of the renal pelvis and ureter. J Natl Cancer Inst 1974; 52:1431.PubMedGoogle Scholar

Blasentumoren

  1. Anderstrom C et al: A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 1983; 9:142PubMedGoogle Scholar
  2. Babaian RJ et al: Metastases from transitional cell carcinoma of urinary bladder. Urology 1980; 16:142PubMedCrossRefGoogle Scholar
  3. Benson RC Jr: Treatment of diffuse transitional cell carcinoma in situy by whole bladder hematoporphyrin derivative Photodynamic therapy. J Urol 1985; 134:675PubMedGoogle Scholar
  4. Boileau MA et al: Bladder carcinoma: Results with preoperative radiotherapy and radical cystectomy. Urology 1980; 16:569PubMedCrossRefGoogle Scholar
  5. Botto H et al: Treatment of malignant bladder tumors by iridium-192 wiring. Urology 1980; 16:467PubMedCrossRefGoogle Scholar
  6. Bracken RB, McDonald MW, Johnson DE: Cystectomy for superficial bladder tumors. Urology 1981; 18:459PubMedCrossRefGoogle Scholar
  7. Brosman SA: The use of bacillus Calmette-Quérin in the therapy of bladder carcinoma in situ. J Urol 1985; 134:36PubMedGoogle Scholar
  8. Burnand KG et al: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 1976; 48:55PubMedCrossRefGoogle Scholar
  9. Byar D, Blackard C: Veterans Administration Cooperative Urological Research Group: Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 1977; 10:556PubMedCrossRefGoogle Scholar
  10. Chan RC, Bracken RB, Johnson DE: Single dose whole pelvis megavoltage irradiation for palliative control of hematuria or ureteral obstruction. J Urol 1979; 122:750PubMedGoogle Scholar
  11. Cole P, Hoover R, Fridell GH: Occupation and cancer of the lower urinary tract. Cancer 1972; 29:1250PubMedCrossRefGoogle Scholar
  12. Collan Y, Makinen J, Heikkinen A: Histological grading of transitional cell tumours of the bladder: Value of histological grading (WHO) in prognosis. Eur Urol 1979; 5:311PubMedGoogle Scholar
  13. Connolly JG et al: Relationship between the use of artificial sweeteners and bladder cancer. (Correspondence.) Can Med Assoc J 1978; 119:408PubMedGoogle Scholar
  14. Cummings KB et al: Segmental resection in the management of bladder carcinoma. J Urol 1978; 119:56PubMedGoogle Scholar
  15. Dan RO: Grading of epithelial tumors of urinary bladder. J Urol 1936; 36:651Google Scholar
  16. de Kernion JB et al: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Quérin. J Urol 1985; 133:598Google Scholar
  17. Dretler SP, Ragsdale BD, Leadbetter WF: The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol 1973; 109:414PubMedGoogle Scholar
  18. England HR et al: Evaluation of Helmstein’s distention method for carcinoma of the bladder. Br J Urol 1973; 45:593PubMedCrossRefGoogle Scholar
  19. Falor WH, Ward RM: Prognosis in early carcinoma of the bladder based on chromosomal analysis. J Urol 1978; 119:44PubMedGoogle Scholar
  20. Falor WH, Ward RM: Prognosis in well-differentiated noninvasive carcinoma of the bladder based on chromosomal analysis. Surg Gynecol Obstet 1977; 144:515PubMedGoogle Scholar
  21. Fisher MR, Hricak H, Tanagho EA: Urinary bladder MR imaging. 2. Neoplasm. Radiology 1985; 157–471Google Scholar
  22. Hall RR: Intravesical hyperthermia for transitional cell carcinoma of the bladder. Pages 267–270 in: Bladder Tumors and Other Topics in Urological Oncology. Vol 1. Pavone-Macaluso M, Smith PH, Edsmyr F (editors). Plenum Press, 1980Google Scholar
  23. Glashan RW: Treatment of carcinoma in situ of the bladder with doxorubicin (Adriamycin). Cancer Chemother Pharmacol 1983; II (Suppl): S35Google Scholar
  24. Hatch TR, Barry JM: Value of excretory urography in staging bladder cancer. J Urol 1986; 135:49PubMedGoogle Scholar
  25. Heney NM: First-line chemotherapy of superficial bladder cancer: Mitomycin vs thiotepa. Urology 1985; 26 (Suppl): 27PubMedCrossRefGoogle Scholar
  26. Herr HW et al: Long-term effect of intravesical bacillus Calmette-Guérin on flat carcinoma in situ of bladder. J Urol 1986; 135:265PubMedGoogle Scholar
  27. Hewitt CB, Babiszewski JF, Antunez AR: Update on intracavitary radiation in the treatment of bladder tumors. J Urol 1981; 126:323PubMedGoogle Scholar
  28. Hicks RM: Multistage carcinogenesis in the urinary bladder. Br Med Bull 1980; 36:39PubMedGoogle Scholar
  29. Hicks RM, Chowaniec J, Wakefield J: Experimental induction of bladder tumors by a two-stage system. Pages 475–489 in: Carcinogenesis: Mechanisms of Tumor Promotion and Cocarcinogenesis. Vol 2. Slaga TJ, Sivak A, Boutwell RK (editors). Raven, 1978Google Scholar
  30. Hope-Stone HF et al: T3 bladder cancer: Salvage rather than elective cystectomy after radiotherapy. Urology 1984; 24:315PubMedCrossRefGoogle Scholar
  31. International Union Against Cancer: TNM Classification of Malignant Tumors, 3rd ed. International Union Against Cancer, 1978Google Scholar
  32. Itzchak Y, Singer D, Fischelavitch Y: Ultrasonographic assessment of bladder tumors. 1. Tumor detection. J Urol 1981; 126:31PubMedGoogle Scholar
  33. Jakse G, Hofstädter F, Marberger H: Topical doxorubicin hydrochloride therapy for carcinoma in situ of bladder: A follow-up. J Urol 1984; 131:41PubMedGoogle Scholar
  34. Javadpour N: Current status of biological markers in bladder and testis cancer. Lesson 13 in: American Urological Association Update Series. Vol 1. American Urological Association, 1982Google Scholar
  35. Jewett HJ, Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 1946; 55:366PubMedGoogle Scholar
  36. Johnson DE: Surgery for carcinoma of the urinary bladder. Cancer Treat Rev 1974; 1:271PubMedCrossRefGoogle Scholar
  37. Klein FA et al: Flow cytometry of normal and nonneoplastic diseases of the bladder: An estimate of the false-positive rates. J Urol 1982; 127:946PubMedGoogle Scholar
  38. Koss LG: Tumors of the Urinary Bladder, Fascicle II of: Atlas of Tumor Pathology, 2nd series. Armed Forces Institute of Pathology, 1975Google Scholar
  39. Lamm DL: Bacillus Calmette-Quérin-immunotherapy for bladder cancer. J Urol 1985; 134:40PubMedGoogle Scholar
  40. Lamm DL et al: Complications of bacillus Calmette-Quérin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986; 135:272PubMedGoogle Scholar
  41. La Plante M, Brice M II: The upper limits of hopeful application of radical cystectomy for vesical carcinoma: Does nodal metastasis always indicate incurability? J Urol 1973; 109:261Google Scholar
  42. Lerman RI, Hutter RVP, Whitmore WF Jr: Papilloma of the urinary bladder. Cancer 1970; 25:333PubMedCrossRefGoogle Scholar
  43. Logothesis CJ et al: Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. J Urol 1985; 134:460Google Scholar
  44. Marshall VF: The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 1952; 68:174Google Scholar
  45. Martínez-Piñeiro JA: BCG vaccine in superficial bladder tumors: Eight years later. Eur Urol 1984; 10:93PubMedGoogle Scholar
  46. Masina F: Segmental resection for tumours of the urinary bladder: Ten year follow-up. Br J Surg 1965; 52:279PubMedCrossRefGoogle Scholar
  47. Mathur VK, Krahn HP, Ramsey EW: Total cystectomy for bladder cancer. J Urol 1981; 125:784PubMedGoogle Scholar
  48. McAninch JW, Kiesling VJ, Beck PN: Diagnostic biopsies of bladder and urethra in outpatients. Page 19 in: Proceedings of the Kimbrough Urological Seminar. Vol 12. Brodock Press, 1978Google Scholar
  49. Meyers FJ et al: Fate of bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: Northern California oncology group study. J Urol 1985; 134:1118PubMedGoogle Scholar
  50. Miller LS, Johnson DE: Megavoltage irradiation for bladder cancer: Alone, postoperative, or preoperative. Pages 771–782 in: Seventh National Cancer Conference Proceedings, Lippincott, 1973Google Scholar
  51. Montie JE, Straffon RA, Stewart BH: Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984; 131:477PubMedGoogle Scholar
  52. Morrison AS, Buring JE: Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med 1980; 302:537PubMedCrossRefGoogle Scholar
  53. Mostofi FK: Pathology and staging of bladder cancer. Pages 213–218 in: Advances in Medical Oncology, Research and Education. Vol 11: Clinical Cancer: Principal Sites 2. Wilkinson PM (editor). Pergamon, 1979Google Scholar
  54. Mostofi FK, Sobin LH, Toriini H: Histological Typing of Urinary Bladder Tumours. World Health Organization, 1973Google Scholar
  55. Newell GR, Hoover RN, Kolbye AC: Status report on saccharin in humans. J Natl Cancer Inst 1978; 61:275PubMedGoogle Scholar
  56. Nseyo UO et al: Whole bladder photodynamic therapy for transitional cell carcinoma of bladder. Urology 1985; 26:274PubMedCrossRefGoogle Scholar
  57. Ojeda L, Johnson DE: Partial cystectomy: Can it be incorporated into an integrated program? Urology 1983; 12:115CrossRefGoogle Scholar
  58. Periss JA, Waterhouse K, Cole AT: Complications of partial cystectomy in patients with high grade bladder carcinoma. J Urol 1977; 118:761Google Scholar
  59. Pinsky CM et al: Intravesical administration of bacillus Cal-mette-Quérin in patients with recurrent superficial carcinoma of the urinary bladder: Report of a prospective, randomized trial. Cancer Treat Rep 1985; 69:47PubMedGoogle Scholar
  60. Purtilo DT et al: Familial urinary bladder cancer. Semin Oncol 1979; 6:254PubMedGoogle Scholar
  61. Resnick MI, Kursh ED: Transurethral ultrasonography in bladder cancer. J Urol 196; 135:253Google Scholar
  62. Resnick MI, O’Conor VJ Jr: Segmental resection for carcinoma of the bladder: Review of 102 patients. J Urol 1973; 109:1007PubMedGoogle Scholar
  63. Rider WD, Evans DH: Radiotherapy in the treatment of recurrent bladder cancer. Br J Urol 1976; 48:595PubMedCrossRefGoogle Scholar
  64. Sandberg AA: Chromosome studies in bladder cancer. Pages 127–141 in: Carcinoma of the Bladder. Connolly JG (editor). Raven, 1981Google Scholar
  65. Schellhammer PF, Ladaga LE, Fillion MB: Bacillus Call-mette-Quérin for superficial transitional cell carcinoma of bladder. J Urol 1986; 135:261PubMedGoogle Scholar
  66. Shipley WU, Rose MA: Bladder cancer: The selection of patients for treatment by full-dose irradiation. Cancer 1985; 55:2278Google Scholar
  67. Silverberg E: Cancer statistics, 1981, CA 1981; 31:13PubMedGoogle Scholar
  68. Soloway MS: Treatment of superficial bladder cancer with intravesical mitomycin C: Analysis of immediate and long-term response in 70 patients. J Urol 1985; 134:1107PubMedGoogle Scholar
  69. Stein BS et al: Specific red cell adherence: Immunologic evaluation of random mucosal biopsies in carcinoma of the bladder. J Urol 1981; 126:37PubMedGoogle Scholar
  70. Sternberg CN et al: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985; 133:403PubMedGoogle Scholar
  71. Utz DC, Farrow GM: Management of carcinoma in situ of the bladder: The case for surgical management. Urol Clin North Am 1980; 7:533PubMedGoogle Scholar
  72. Utz DC et al: A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder. Cancer 1973; 32:1075PubMedCrossRefGoogle Scholar
  73. van der Werf-Messing B: Cancer of the urinary bladder treated by intestitial radium implant. Int J Radiat Oncol Biol Phys 1978; 4:373PubMedGoogle Scholar
  74. van der Werf-Messing B: Carcinoma of the bladder T3N2M0 treated by preoperative irradiation followed by cystectomy: Third report of the Rotterdam Radio-Therapy Institute. Cancer 1975; 36:718PubMedCrossRefGoogle Scholar
  75. Veenema RJ et al: Bladder carcinoma treated by direct instillation of thiotepa. J Urol 1962; 88:60PubMedGoogle Scholar
  76. Veenema RJ et al: Thiotepa bladder instillations: Therapy and prophylaxis for superficial bladder tumors. J Urol 1969; 101:711PubMedGoogle Scholar
  77. Wallace DM, Bloom HJG: The management of deeply infiltrating (T3) bladder carcinoma: Controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy. Br J Urol 1976; 48:587PubMedCrossRefGoogle Scholar
  78. Whitmore WF Jr: Integrated irradiation and cystectomy for bladder cancer. Br J Urol 1980; 52:1PubMedCrossRefGoogle Scholar
  79. Wigle DT: Bladder cancer: Possible new high-risk occupation. Lancet 1977; 2:83PubMedCrossRefGoogle Scholar
  80. Wynder EL, Goldsmith K: The epidemiology of bladder cancer: A second look. Cancer 1977; 40:1246PubMedCrossRefGoogle Scholar
  81. Zincke H et al: Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease. Br J Urol 1985; 57:156PubMedCrossRefGoogle Scholar

Prostatatumoren

  1. Armenian HK et al: Relationship between benign prostatic hyperplasia and cancer of the prostate. Lancet 1974; 2:115PubMedCrossRefGoogle Scholar
  2. Franks LM: Benign nodular hyperplasia of the prostate: A review. Ann R Coll Surg Engl 1954; 14:92Google Scholar
  3. Geraghty JT: Treatment of malignant disease of the prostate and bladder. J Urol 1922; 7:33Google Scholar
  4. Greenwald P et al: Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 1974; 53:335PubMedGoogle Scholar
  5. Hodges CV, Wan ST: The relationship between benign prostatic hyperplasia and prostatic carcinoma. Pages 167–173 in: Benign Prostatic Hypertrophy. Hinman F Jr (editor). Springer-Verlag, 1983Google Scholar
  6. Lowsley OS: The development of the human prostate gland with reference to the development of the other structures at the neck of the urinary bladder. Am J Anat 1912:13:299CrossRefGoogle Scholar
  7. McNeil JE: Regional morphology and pathology of the prostate. Prostate 1981; 2:35.CrossRefGoogle Scholar

Gutartige Prostatahyperplasie

  1. Andersen JT, Nording J: Prostatism. 1. The correlation between symptoms: Cystometric and urodynamic findings. Scand J Urol Nephrol 1979; 13:229PubMedCrossRefGoogle Scholar
  2. Cabot AT: The question of castration for enlarged prostate. Ann Surg 1896; 24:265PubMedCrossRefGoogle Scholar
  3. Caine M, Perlberg S, Gordon R: The treatment of benign prostatic hypertrophy with flutamide (SCH 13521): A placebo-controlled study. J Urol 1975; 114:564PubMedGoogle Scholar
  4. Caine M, Perlberg S, Meretyk S: A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol 1978; 50:551PubMedCrossRefGoogle Scholar
  5. Donkervoort TK et al: Megestrol acetate in treatment of benign prostatic hypertrophy. Urology 1975; 6:580PubMedCrossRefGoogle Scholar
  6. Geller J et al: Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy. Urology 1979; 14:467PubMedCrossRefGoogle Scholar
  7. Huggins C, Stevens RA: The effect of castration on benign hypertrophy of the prostate in man. J Urol 1940:43:705Google Scholar
  8. Lytton B, Emery JM, Harvard BM: The incidence of benign prostatic obstruction. J Urol 1968; 99:639PubMedGoogle Scholar
  9. Mebust WK, Valk WL: Transurethral prostatectomy. Pages 829–846 in: Benign Prostatic Hypertrophy. Hin-man F Jr (editor). Springer-Verlag, 1983Google Scholar
  10. Melchior J et al: Transurethral prostatectomy: Computerized analysis of 2.223 consecutive cases. J Urol 1974; 112:634PubMedGoogle Scholar
  11. Melchior J et al: Transurethral prostatectomy in the azotemic patient. J Urol 1974; 112:643PubMedGoogle Scholar
  12. Neubauer DL: Endocrine and cellular inductive factors in the development of human benign prostatic hypertrophy. Pages 179–192 in: Benign Prostatic Hypertrophy. Hin-man F Jr (editor). Springer-Verlag, 1983Google Scholar
  13. Scott WW, Wade JC: Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate. J Urol 1969; 101:81PubMedGoogle Scholar
  14. Walsh A et al: Indications for prostatectomy: Mandatory and optional. Pages 771–775 in: Benign Prostatic Hypertrophy. Hinman F Jr (editor). Springer-Verlag, 1983Google Scholar
  15. Walsh PC, Hutchins GM, Ewing LL: Tissue content of dehydrotestosterone in human prostatic hyperplasia is not supranormal. J Clin Invest 1983; 72:1772PubMedCrossRefGoogle Scholar
  16. White JW: The results of double castration in hypertrophy of the prostate. Ann Surg 1895; 22:1PubMedCrossRefGoogle Scholar

Prostatakarzinom

  1. Bagshaw MA: Radiotherapy of prostatic cancer: Stanford University experience. Prog Clin Biol Res 1984; 153:493PubMedGoogle Scholar
  2. Bass RB Jr, Barrett DM: Radical retropubic prostatectomy after transurethral prostatic resection. J Urol 1980; 124:495PubMedGoogle Scholar
  3. Bonar RA: Carcinogenesis in urogenital tissues in genitourinary cancer. In: Cancer Treatment and Research. Vol 6. Paulson DF (editor). Martinus Nijhoff, 1982Google Scholar
  4. Brackman J, Denis L: The practice and pitfalls of ultrasonography in the lower urinary tract. Eur Urol 1983; 9:193Google Scholar
  5. Brawn PN et al: Histologic grading study of prostatic adenocarcinoma: The development of a new system and comparison with other methods. A preliminary study. Cancer 1982; 49:525PubMedCrossRefGoogle Scholar
  6. Bridges CH et al: Stage A prostatic carcinoma and repeat transurethral resection: A reappraisal 5 years later. J Urol 1983; 129:307PubMedGoogle Scholar
  7. Broder AC: Carcinoma grading and practical applications. Arch Pathol 1926; 2:376Google Scholar
  8. Byar DP: Survival of patients with incidentally found microscopic cancer of the prostate: Results of a clinical trial of conservative treatment. J Urol 1972; 108:908PubMedGoogle Scholar
  9. Byar DP, Mostofi FK, Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 1972; 30:5PubMedCrossRefGoogle Scholar
  10. Catalona WJ, Stein AJ: Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. J Urol 1982; 127:460PubMedGoogle Scholar
  11. Clark P, Houghton L: Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 1977; 49:419PubMedCrossRefGoogle Scholar
  12. Cox JD, Stoffel TJ: The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 1977; 40:156PubMedCrossRefGoogle Scholar
  13. Foti AG et al: The detection of prostatic cancer by solid phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med 1977; 297:1357PubMedCrossRefGoogle Scholar
  14. Franks LM: Latent carcinoma of the prostate. J Urol Pathol Bacteriol 1954; 68:603CrossRefGoogle Scholar
  15. Freiha FS, Bagshaw MA: Carcinoma of the prostate: Results of postirradiation biopsy. Prostate 1984; 5:19PubMedCrossRefGoogle Scholar
  16. Freiha FS, Pistenma DA, Bagshaw MA: Pelvic lymph-adenectomy for staging prostatic carcinoma: Is it always necessary? J Urol 1979; 122:176PubMedGoogle Scholar
  17. Gagnon JD, Moss WT, Stevens KR: Preestrogen breast irradiation for patients with carcinoma of the prostate: A critical review. J Urol 1979; 121:182PubMedGoogle Scholar
  18. Gleason DF, Mellinger GT: Veterans Administration Cooperative Urologic Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58PubMedGoogle Scholar
  19. Guerriero WG, Carlton CE Jr, Hudgins PT: Combined interstitial and external radiotherapy in the definitive management of carcinoma of the prostate. Cancer 1980; 45:1922PubMedGoogle Scholar
  20. Hanash KA et al: Carcinoma of the prostate: A 15 year follow-up. J Urol 1972; 107:450PubMedGoogle Scholar
  21. Herr HW: Complication of pelvic lymphadenectomy and retropubic prostatic 125I implantation. Urology 1979; 14:226PubMedCrossRefGoogle Scholar
  22. Hirayama T: Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 1979; 53:149PubMedGoogle Scholar
  23. Jacobs SC: Spread of prostatic cancer to bone. Urology 1983; 21:337PubMedCrossRefGoogle Scholar
  24. Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975; 2:105PubMedGoogle Scholar
  25. Johnson DE, von Eschenbach AC: Prostatic carcinoma: A trilogy of expressions. South Med J 1980; 73:1304PubMedCrossRefGoogle Scholar
  26. Johnson DE, von Eschenbach AC: Role of lymphangiography and pelvic lymphadenectomy in staging prostatic carcinoma. J Urol 1981; 17 (Suppl):66Google Scholar
  27. Jordan WP Jr, Blackard CE, Byar DP: Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South Med J 1977; 70:1411PubMedGoogle Scholar
  28. Kuriyama M et al: Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. J Natl Cancer Inst 1982; 68:99PubMedGoogle Scholar
  29. Labrie F et al: New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens. Prostate 1983; 4:579PubMedCrossRefGoogle Scholar
  30. Lee F et al: Transrectal ultrasound in the diagnosis of prostate carcinoma: Location, echogenicity, histopathology, staging. Prostate 1985; 7:117PubMedCrossRefGoogle Scholar
  31. Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984; 311:1281CrossRefGoogle Scholar
  32. Logothetis CJ et al: Doxorubicin, mitomycin C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal-refractory adenocarcinoma of the prostate, with a note on the staging of metastatic cancer. J Clin Oncol 1983; 1:368PubMedGoogle Scholar
  33. McLaughlin AP et al: Prostatic carcinoma: Incidence and location of unsuspected lymphatic metastases. J Urol 1976; 115:89PubMedGoogle Scholar
  34. McMilien SM, Wettlaufer JN: The role of repeat transurethral biopsy in stage A carcinoma of the prostate. J Urol 1976; 116:759Google Scholar
  35. Middleton RG, Smith JA Jr: Radical prostatectomy for stage B2 prostatic cancer. J Urol 1982; 127:702PubMedGoogle Scholar
  36. Mostofi FK: Grading of prostatic carcinoma. Cancer Chemother Res 1975; 59:111Google Scholar
  37. Murphy GP: Chemotherapy of advanced prostatic cancer. Rev Surg 1977; 34:75PubMedGoogle Scholar
  38. Nesbitt RM, Baum WC: Endocrine control of prostatic carcinoma. JAMA 1950:143:1317Google Scholar
  39. Nichols RT, Barry JM, Hodges CV: The morbidity of radical prostatectomy for multifocal stage I prostatic adenocarcinoma. J Urol 1977; 117:83PubMedGoogle Scholar
  40. Paulson DF, Urologic Oncology Research Group: The impact of current staging procedures in assessing disease extent of prostatic carcinoma. J Urol 1979; 121:300Google Scholar
  41. Rich AR: On the frequency of occurrence of occult carcinoma of the prostate. J Urol 1935; 33:215Google Scholar
  42. Rotkin ID: Epidemiologic studies in prostatic cancer. Cancer Treat Rep 1977; 61:173PubMedGoogle Scholar
  43. Schroeder FH, Belt E: Carcinoma of the prostate: A study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 1975; 114:257PubMedGoogle Scholar
  44. Seamonds B et al: Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology 1986; 28:472PubMedCrossRefGoogle Scholar
  45. Sheldon CA et al: Incidental carcinoma of the prostate: A review of the literature and critical appraisal of classification. J Urol 1980; 124:626PubMedGoogle Scholar
  46. Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: A continuing cooperative study. J Urol 1964; 91:590Google Scholar
  47. Walsh PC: Physiologic basis for hormonal therapy in carcinoma of the prostate. Urol Clin North Am 1975; 2:125PubMedGoogle Scholar
  48. Walsh PC, Donker PJ: Impotence following radical prostatectomy. J Urol 1982; 128:492PubMedGoogle Scholar
  49. Walsh PC, Jewett HJ: Radical surgery for prostatic cancer. Cancer 1980; 45 (Suppl 7): 1906PubMedGoogle Scholar
  50. Whitmore WF Jr: Hormone therapy in prostatic cancer. Am J Med 1956; 21:697PubMedCrossRefGoogle Scholar
  51. Whitmore WF Jr: The natural history of prostatic cancer. Cancer 1973; 32:1104PubMedCrossRefGoogle Scholar
  52. Whitmore WF Jr, Hilaris B, Grabstald H: Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J Urol 1972; 109:918Google Scholar
  53. Winkelstein W Jr, Ernster VL: Epidemiology and etiology in prostatic cancer. Page 1 in: Prostatic Cancer. Murphy GP (editor). PSG Publishing, 1979Google Scholar
  54. Zincke H et al: Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer 1981; 47:1901PubMedCrossRefGoogle Scholar

Tumoren der Prostatagänge

  1. Dube VE, Farrow GM, Greene LF: Prostatic adenocarcinoma of ductal origin. Cancer 1973; 32:402PubMedCrossRefGoogle Scholar
  2. Greene LF et al: Prostatic adenocarcinoma of ductal origin. J Urol 1979; 121:303PubMedGoogle Scholar

Tumoren der Samenblasen

  1. Lathem JE: Carcinoma of seminal vesicle. South Med J 1975; 68:473PubMedCrossRefGoogle Scholar

Tumoren der Urethra

  1. Bracken RB, Henry R, Ordonez N: Primary carcinoma of the male urethra. South Med J 1980; 73:1003PubMedCrossRefGoogle Scholar
  2. Grabstald H et al: Cancer of the female urethra. JAMA 1966; 197:835PubMedCrossRefGoogle Scholar
  3. Johnson DE, O’Connell JR: Primary carcinoma of the female urethra. Urology 1983; 12:115Google Scholar
  4. Johnson DE, O’Connell JR, Delclos L: Cancer of the urethra. In: Principles and Management of Urologic Cancer, 2nd ed. Javadpour N (editor). Williams & Wil-kins, 1983Google Scholar
  5. Johnson DE et al: Rotational skin flaps to cover wound defect in groin. Urology 1975; 6:461PubMedCrossRefGoogle Scholar
  6. Marshall FC, Uson AC, Melicow MM: Neoplasms and caruncles of the female urethra. Surg Gynecol Obstet 1960; 110:723PubMedGoogle Scholar
  7. Ray B, Guinan PD: Primary carcinoma of the urethra. In: Principles and Management of Urologic Cancer. Javadpour N (editor). Williams & Wilkins, 1979Google Scholar
  8. Shuttleworth KED, Lloyd-Davies RW: Radical resection for tumors invading the posterior urethra. Br J Urol 1969; 41:739PubMedCrossRefGoogle Scholar
  9. Zeigerman JH, Gordon SF: Cancer of the female urethra: A curable disease. Obstet Gynecol 1970; 36:785PubMedGoogle Scholar

Tumoren des Samenstrangs und des paratestikulären Gewebes

  1. Adrien M, Grabstald H, Whitmore WF Jr: Malignant tumors of the spermatic cord. Cancer 1969; 23:525CrossRefGoogle Scholar
  2. Banowsky LH, Schultz GN: Sarcoma of the spermatic cord and tunica: Review of the literature, case report and discussion of the role of retroperitoneal lymph node dissection. J Urol 1970; 103:628PubMedGoogle Scholar
  3. Johnson DE, Harris JD, Ayala AG: Liposarcoma of spermatic cord Urology 1978; 11:190Google Scholar
  4. Johnson RB Jr et al: Paratesticular rhabdomyosarcoma in childhood. Cancer 1978; 42:729CrossRefGoogle Scholar
  5. Wertzner S: Leiomyosarcoma of the spermatic cord and uteroperitoneal lymph node dissection. Am Surg 1973; 39:352 HodentumorenGoogle Scholar
  6. Babaian RJ, Johnson DE: Management of stage I and II nonseminomatous germ cell tumors of the testis. Cancer 1980; 45:1775PubMedCrossRefGoogle Scholar
  7. Ball D, Barrett A, Peckham MJ: The management of metastatic seminoma testis. Cancer 1982; 50:2289Google Scholar
  8. Belville WD et al: The liver scan in urologic oncology. J Urol 1980;123:901PubMedGoogle Scholar
  9. Berthelsen JG et al: Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J 1982; 285:1683CrossRefGoogle Scholar
  10. Boden G, Ribb R: Radiotherapy in testicular neoplasms. Lancetz 1951; 2:1195CrossRefGoogle Scholar
  11. Borski AA: Diagnosis, staging and natural history of testicular tumor. Cancer 1973; 32:1202PubMedCrossRefGoogle Scholar
  12. Bowman WP et al: Isolated testicular relapse in acute lymphocytic leukemia of childhood: Categories and influence on survival. J Clin Oncol 1984; 2:924PubMedGoogle Scholar
  13. Bracken RB et al: The role of surgery following chemotherapy in stage III germ cell neoplasms. J Urol 1983; 129:39PubMedGoogle Scholar
  14. Braunstein GD et al: Ectopic production of human chorionic gonadotropin by neoplasms. Ann Intern Med 1973; 78:39PubMedGoogle Scholar
  15. Caldwell WL: Why retroperitoneal lymphadenectomy for testicular tumors? J Uro 1978; 119:754Google Scholar
  16. Cancer Facts and Figures, 1979, American Cancer Society, 1978Google Scholar
  17. Collins DH, Pugh RCB: Classification and frequency of testicular tumors. Br J Urol 1964; 36 (Suppl): 1PubMedGoogle Scholar
  18. Dixon FH, Moore RA: Tumors of the Male Sex Organs, Armed Forces Institute of Pathology, 1952Google Scholar
  19. Donohue JP, Rowland RG: The role of surgery in advanced testicular cancer. Cancer 1984; 54:2716Google Scholar
  20. Donohue JP, Einhorn LH, Williams SD: Cytoreductive surgery for metastatic testis cancer: Considerations of timing and extent. J Urol 1980; 123:876PubMedGoogle Scholar
  21. Donohue JP, Einhorn LH, Williams SD: Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testicular cancer necessary? Urol Clin North Am 1980; 7:747PubMedGoogle Scholar
  22. Donohue JP, Zachary JM, Maynard BR: Distribution of total metastases in nonseminomatous testis cancer. J Urol 1982;128:315PubMedGoogle Scholar
  23. Donohue JP et al: Cytoreductive surgery for metastatic testicular cancer: Analysis of retroperitoneal masses after chemotherapy. J Urol 1982; 127:1111PubMedGoogle Scholar
  24. Forrest JB, Sabio H, Howards SS: Testicular relapse in acute childhood leukemia. J Surg Oncol 1982; 21:132PubMedCrossRefGoogle Scholar
  25. Freiha FS et al: The extent of surgery after chemotherapy for advanced germ cell tumors. J Urol 1984; 132:915PubMedGoogle Scholar
  26. Friedman EL et al: Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 1985; 3:1325PubMedGoogle Scholar
  27. Friedman NB, Moore RA: Tumors of the testis: A report of 922 cases. Milit Med 1946; 99:573Google Scholar
  28. Gallager HS: Pathology of testicular and peritesticular neoplasms. Pages 1–30 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976Google Scholar
  29. Hoskin P et al: Prognostic factors in stage I Nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: Implications for adjuvant chemotherapy. J Clin Oncol 1986; 4:1031PubMedGoogle Scholar
  30. Hudson MM et al: Diagnostic value of surgical testicular biopsy after therapy for acute lymphocytic leukemia. J Pediatr 1985; 107:50PubMedCrossRefGoogle Scholar
  31. Javadpour N: Tumor markers in urologic cancer. Urology 1980; 16:127PubMedCrossRefGoogle Scholar
  32. Javadpour N, Moley J: Alternative to retroperitoneal lymphadenectomy with preservation of ejaculation and fertility in stage I nonseminomatous testicular cancer: A prospective study. Cancer 1985; 55:1604PubMedCrossRefGoogle Scholar
  33. Javadpour N et al: The role of radioimmunodetection in the management of testicular cancer. JAMA 1981; 246:45PubMedCrossRefGoogle Scholar
  34. Jeppsson A et al: A clinical evaluation of serum placental alkaline phosphatase in seminoma patients. Br J Urol 1983; 55:73PubMedCrossRefGoogle Scholar
  35. Johnson DE: Clinical staging. Pages 131–144 in: Testis Tumors. Donohue JP (editor). Williams & Wilkins, 1983Google Scholar
  36. Johnson DE: Epidemiology. Pages 37–46 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976Google Scholar
  37. Johnson DE, Ayala AG: Secondary neoplasms of the testis. Pages 249–260 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976Google Scholar
  38. Johnson DE, Bracken RB, Blight EM: Prognosis for pathologic stage I nonseminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy. J Urol 1976; 116:63PubMedGoogle Scholar
  39. Johnson DE, Butler JJ: Malignant lymphoma of the testis. Pages 234–248 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976Google Scholar
  40. Johnson DE, Gomez JJ, Ayala AG: Anaplastic seminoma. J Urol 1975; 114:80PubMedGoogle Scholar
  41. Johnson DE et al: Metastases from testicular carcinoma: Study of 78 autopsied cases. Urology 1976; 8:234PubMedCrossRefGoogle Scholar
  42. Johnson DE et al: Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: Preliminary results. J Urol 1984; 131:491PubMedGoogle Scholar
  43. Kaswick JA, Bloomberg SD, Skinner DG: Radical retroperitoneal lymph node dissection: How effective is removal of all retroperitoneal nodes? J Urol 1976; 115:70PubMedGoogle Scholar
  44. Kim I, Young RH, Scully RE: Leydig cell tumors of the testis: A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 1985; 9:177PubMedCrossRefGoogle Scholar
  45. Klein FA, Melamed MR, Whitmore WF Jr: Intratubular malignant germ cells (carcinoma in situ) accompanying invasive testicular germ cell tumors. J Urol 1985; 133:413PubMedGoogle Scholar
  46. Kreuser ED et al: Bulky germinal tumors: Comparison of different induction regimens and significance of residual disease. Eur Urol 1985; 11:163PubMedGoogle Scholar
  47. Lange PH et al: Is SP-1 a marker for testicular cancer? Urology 1980; 15:251PubMedCrossRefGoogle Scholar
  48. Li SP, Connelly RR, Myers M: Improved survival rates among testicular cancer patients in the US. JAMA 1982; 247:825PubMedCrossRefGoogle Scholar
  49. Logothetis CJ et al: The growing teratoma syndrome. Cancer 1982; 50:1629PubMedCrossRefGoogle Scholar
  50. Logothetis CJ et al: Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. J Clin Oncol 1985; 3:326PubMedGoogle Scholar
  51. Logothetis CJ et al: Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: A preliminary report. J Urol 1985; 134:1127PubMedGoogle Scholar
  52. Melicow MM: The British classification of testicular tumors: A correlation, analysis and critique. J Urol 1965; 94:64PubMedGoogle Scholar
  53. Mills PK, Newell GR, Johnson DE: Familial patterns of testicular cancer. Urology 1984; 24:1PubMedCrossRefGoogle Scholar
  54. Niruyana B et al: Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis: Importance in “surveillance only” protocols. Cancer 1985; 56:2492Google Scholar
  55. Mostofi SK: Testicular tumors: Epidemiologic, etiologic, and pathologic features. Cancer 1973; 32:1186PubMedCrossRefGoogle Scholar
  56. Mostofi SK, Price RB Jr: Tumors of the Male Genital System. Armed Forces Institute of Pathology, 1973Google Scholar
  57. Mostofi SK, Sobin LH: International Histologic Classification of Tumors. No. 16. Histological Typing of Testis Tumors. World Health Organization, 1977Google Scholar
  58. Müller J et al: Cryptorchidism and testis cancer: A typical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer 1984; 54:629PubMedCrossRefGoogle Scholar
  59. Patterson AHG, Peckham MJ, McCready VR: Value of gallium-scanning in seminoma of the testis. Br Med J 1977; 1:1118CrossRefGoogle Scholar
  60. Patton JF, Mallis N: Tumors of the testis. J Urol 1959; 81:457PubMedGoogle Scholar
  61. Pearson JC: Endocrinology of testicular neoplasms. Urology 1981; 17:119PubMedCrossRefGoogle Scholar
  62. Peckham MJ, Hendry WF: Clinical stage II nonseminomatous germ cell testicular tumours: Results of management by primary chemotherapy. Br J Urol 1985; 57:763PubMedCrossRefGoogle Scholar
  63. Pierce GB: Ultrastructure of human testicular cancer. Cancer 1966; 19:1963PubMedCrossRefGoogle Scholar
  64. Pizzocaro G, Monfardini S: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 1984; 131:677PubMedGoogle Scholar
  65. Pizzocaro G, Salvioni R, Zanoni F: Unilateral lymph-adenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol 1985; 134:485PubMedGoogle Scholar
  66. Pizzocaro G et al: Surveillance or lymph node dissection in clinical stage I nonseminomatous germinal testis cancer? Br J Urol 1985; 57:759PubMedCrossRefGoogle Scholar
  67. Pui CH et al: Elective testicular biopsy during chemotherapy for childhood leukaemia is of no clinical value. Lancet 1985; 2:410PubMedCrossRefGoogle Scholar
  68. Richie JP, Garnick MB: Limited retroperitoneal lymph-adenectomy for patients with clinical stage I testicular tumor. (Abstract.) Proc Am Soc Clin Oncol 1985; 4:110Google Scholar
  69. Rosai J, Silber I, Khodadoust K: Spermatocytic seminoma. 1. Clinicopathologic study of six cases and review of the literature. Cancer 1969; 24:92PubMedCrossRefGoogle Scholar
  70. Rosai J, Khodadoust K, Silber I: Spermatocytic seminoma. 2. Ultrastructural study. Cancer 1969; 24:103PubMedCrossRefGoogle Scholar
  71. Rouviere H: Anatomie de lymphatiques de l’homme. Maison et Cie, 1932Google Scholar
  72. Safer ML et al: Lymphangiographic accuracy in the staging of testicular tumors. Cancer 1975; 35:1603PubMedCrossRefGoogle Scholar
  73. Samuels ML et al: Combination chemotherapy in germinal tumors. Cancer Treat Rev 1976; 3:185PubMedCrossRefGoogle Scholar
  74. Scardino PT: Adjuvant chemotherpay is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors. Urol Clin North Am 1980; 7:735PubMedGoogle Scholar
  75. Schover LR, von Eschenbach AC: Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 1985; 25:251PubMedCrossRefGoogle Scholar
  76. Sogani PC et al: Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol 1984; 2:267PubMedGoogle Scholar
  77. Stevens LC: Origin of testicular teratoma from primordial germ cells in mice. J Natl Cancer Inst 1967; 138:549Google Scholar
  78. Stoter G et al: Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin. Cancer 1984; 54:1521PubMedCrossRefGoogle Scholar
  79. Sussman EB et al: Malignant lymphoma of the testis: A clinical pathologic study of 37 cases. J Urol 1977; 17:1004Google Scholar
  80. Swanson DA: Benefits of early diagnosis of testis cancer. Cancer Bull 1985; 37:291Google Scholar
  81. Swartz DA, Johnson DE, Hussey DH: Should an elevated human chorionic gonadotropin titer alter therapy for seminoma? J Urol 1984; 131:63PubMedGoogle Scholar
  82. Tait D et al: Postchemotherapy surgery in advanced nonseminomatous germ-cell testicular tumours: The significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 1984; 50:601PubMedCrossRefGoogle Scholar
  83. Talerman A: The incidence of yolk sac tumor (endodermal sinus tumor) elements in germ cell tumors of the testis in adults. Cancer 1975; 33:211CrossRefGoogle Scholar
  84. Talerman A, Fu YS, Okagaki T: Spermatocytic seminoma: Ultrastructural and microspectrophotometric observations. Lab Invest 1984; 51:343PubMedGoogle Scholar
  85. Teilum G: The concept of endodermal sinus (yolk sac) tumor. Scand J Immunol 1978; 8 (Suppl):75CrossRefGoogle Scholar
  86. Templeton AC: Testicular neoplasms in Ugandan Africans. Afr J Med Sci 1972; 3:157PubMedGoogle Scholar
  87. Thomas GM: Controversies in the management of testicular seminoma. Cancer 1985; 55 (9 Suppl):2296Google Scholar
  88. Thomas GM et al: Seminoma of the testis: Results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys 1982; 8:165PubMedCrossRefGoogle Scholar
  89. Turner RR, Colby TV, MacKintosh FR: Testicular lymphomas: A clinical pathologic study of 35 cases. Cancer 1981; 48:2095Google Scholar
  90. Tyrrell CJ, Peckham MJ: The response of lymph node metastases of testicular teratoma to radiation therapy. Br J Urol 1976; 48:363PubMedCrossRefGoogle Scholar
  91. Valvo JR, Wilson P, Frank IN: Ultrasonic examination of scrotum: Review of 108 cases. Urology 1983; 22:78PubMedCrossRefGoogle Scholar
  92. Vugrin D, Whitmore WF Jr: The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer. Cancer 1985; 55:1874PubMedCrossRefGoogle Scholar
  93. Vugrin D, Whitmore WF Jr: The VAB-6 regimen in the treatment of metastatic seminoma. Cancer 1984; 53:2422Google Scholar
  94. Vugrin D et al: Adjuvant chemotherapy in non-seminoma-tous testis cancer: “Mini-VAB” regimen. Long-term follow-up. J Urol 1981; 126:49PubMedGoogle Scholar
  95. Vugrin D et al: VAB-6 combination chemotherapy in resected II-B testicular cancer. Cancer 1983; 51:5PubMedCrossRefGoogle Scholar
  96. Waldmann TA, McIntire KR: The use of radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974; 34:1510PubMedCrossRefGoogle Scholar
  97. Wallace S et al: Lymphangiograms: Their diagnosis and therapeutic potential. Radiology 1961; 76:179PubMedGoogle Scholar
  98. Whitmore WF Jr: Surgical treatment of clinical stage I non-seminomatous germ cell tumors of the testis. Cancer Treat Rep 1982; 66:5PubMedGoogle Scholar
  99. Williams SD, Einhorn LH: Clinical stage I testis tumor: The medical oncologist’s view. Cancer Treat Rep 1982; 66:15PubMedGoogle Scholar
  100. Willis RA: Pathology of Tumors. Appleton-Century-Crofts, 1967Google Scholar

Extragonadale Keimzelltumoren

  1. Buskirk SJ et al: Primary retroperitoneal seminomas. Cancer 1982; 49:1934PubMedCrossRefGoogle Scholar
  2. Israel A et al: The results of chemotherapy for extra-gonadal germ-cell tumors in the cisplatin era: The Memorial Sloan-Ketiering Cancer Center experience (1975 to 1982). J Clin Oncol 1985; 3:1073PubMedGoogle Scholar
  3. Jain KK et al: The treatment of extragonadal seminoma. J Clin Oncol 1984; 2:820PubMedGoogle Scholar
  4. Logothetis CJ et al: Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1985; 3:316PubMedGoogle Scholar
  5. Luna MA: Extragonadal germ cell tumors. Pages 261–265 in: Testicular Tumors, 2nd ed. Johnson DE (editor). Med Exam Pub, 1976Google Scholar
  6. Meares EM Jr, Briggs EM: Occult seminoma masquerading as primary extragonadal germinal neoplasms. Cancer 1972; 30:300PubMedCrossRefGoogle Scholar

Nebenhodentumoren

  1. Farrell MA, Donnelly BJ: Malignant smooth muscle tumors of the epididymis. J Urol 1980; 124:151PubMedGoogle Scholar
  2. Mostofi FK, Price EB Jr: Tumors of the Male Genital System. Armed Forces Institute of Pathology, 1973Google Scholar

Penistumoren

  1. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977; 39:456PubMedCrossRefGoogle Scholar
  2. Cartwright RA, Sinson JD: Carcinoma of the penis and cervix. Lancet 1980; 1:97PubMedCrossRefGoogle Scholar
  3. Delclos L: Interstitial irradiation of the penis. Pages 219–225 in: Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Johnson DE, Boileau MA (editors). Grune & Stratton, 1982Google Scholar
  4. Duncan W, Jackson SM: The treatment of early cancer of the penis with megavoltage X-rays. Clin Radiol 1972; 23:246PubMedCrossRefGoogle Scholar
  5. Jackson SM: The treatment of carcinoma of the penis. Br J Surg 1966; 53:33PubMedCrossRefGoogle Scholar
  6. Johnson DE, Ames FC: Groin Dissection Doody DJ (editor). Year Book, 1985Google Scholar
  7. Johnson DE, Lo RK: Complications of groin dissection in prenile cancer: Experience with 101 lymphadenectomies. Urology 1984; 24:312PubMedCrossRefGoogle Scholar
  8. Johnson DE, Lo RK: Management of regional lymph nodes in penile carcinoma: Five-year results following therapeutic groin dissections. Urology 1984; 24:308PubMedCrossRefGoogle Scholar
  9. Johnson DE et al: Verrucous carcinoma of the penis. J Urol 1985; 133:216PubMedGoogle Scholar
  10. Persky L: Epidemiology of the penis. Pages 97–109 in: Tumors of the Male Genital System. Grundmann E, Vah-lensieck W (editors). Springer, 1977Google Scholar
  11. Puras A, Gonzalez-Flores B, Rodriguez R: Treatment of carcinoma of the penis. Pages 143–152 in: Proceedings of the Kimbrough Urological Seminar. Stevenson HG (editor). Brodock Press, 1977Google Scholar
  12. Reddy DG, Baruah IKSM: Carcinogenic action of human smegma. Arch Pathol 1963; 75:414PubMedGoogle Scholar

Tumoren des Skrotums

  1. McDonald MW: Carcinoma of the scrotum. Urology 1982; 19:269PubMedCrossRefGoogle Scholar
  2. Ray B, Whitmore WF Jr: Experience with carcinoma of the scrotum. J Urol 1977; 117:741PubMedGoogle Scholar

Extrarenale retroperitoneale Tumoren

  1. Binder SC, Katz B, Sheridan B: Reproperitoneal liposar-coma. Ann Surg 1978; 187:257PubMedCrossRefGoogle Scholar
  2. Damascelli B et al: Angiography of retroperitoneal tumors: A review. Am J Roentgenol 1975; 124:565Google Scholar
  3. Duncan RE, Evans AT: Diagnosis of primary retroperitoneal tumors. J Urol 1977; 117:19PubMedGoogle Scholar
  4. Kinne DW et al: Treatment of primary and recurrent retroperitoneal liposarcoma: Twenty-five year experience at Memorial Hospital. Cancer 1973; 31:53PubMedCrossRefGoogle Scholar
  5. Polsky MS et al: Retrovesical liposarcoma. Urology 1974; 3:226PubMedCrossRefGoogle Scholar
  6. Sadoughi N et al: Retroperitoneal xanthogranuloma. Urology 1973; 1:470PubMedCrossRefGoogle Scholar
  7. Smith EH, Bartum RJ Jr: Ultrasonic evaluation of pararenal masses. JAMA 1975; 231:51CrossRefGoogle Scholar
  8. Stephans DH et al: Computed tomography of the retroperitoneal space. Radiol Clin North Am 1977; 15:377Google Scholar
  9. Stephens DH et al: Diagnosis and evaluation of retroperitoneal tumors by computed tomography. AJR 1977; 129:395PubMedGoogle Scholar

Chemotherapie bösartiger urologischer Erkrankungen Allgemeine Literatur

  1. Bagshawe KD (editor): Medical Oncology. Blackwell, 1975Google Scholar
  2. Bodansky O: Biochemistry of Human Cancer. Academic Press, 1975Google Scholar
  3. Brodsky I, Kahn SB, Moyer JH: Cancer Chemotherapy: Basic and Clinical Applications. (Twenty-Second Hahnemann Symposium). Grune & Stratton, 1972Google Scholar
  4. Carter SK et al: Chemotherapy of Cancer. Wiley, 1977Google Scholar
  5. Cline MJ, Haskell CM III: Cancer Chemotherapy; 3rd ed. Saunders, 1980Google Scholar
  6. Criss WE, Ono T, Sabine JR (editors): Control Mechanisms in Cancer. Raven Press, 1976Google Scholar
  7. De Vita VT Jr, Hellman S, Rosenberg S: Cancer: Principles and Practice of Oncology. Lippincott, 1982Google Scholar
  8. Dunphy JE: On caring for the patient with cancer. N Engl J Med 1976; 295:313PubMedCrossRefGoogle Scholar
  9. Haskell CM: Cancer Treatment. Saunders, 1980Google Scholar
  10. Holland JF, Frei E III (editors): Cancer Medicine. Lea & Febiger, 1973Google Scholar
  11. Horton J, Hill GJ II (editors): Clinical Oncology. Saunders, 1977Google Scholar
  12. Jones SE, Salmon SE (editors) Adjuvant Therapy of Cancer II. Grune & Stratton, 1977Google Scholar
  13. Krakoff IHG: Cancer chemotherapeutic agents. CA 1977; 27:130PubMedGoogle Scholar
  14. Krakoff IH: (editor): Symposium on medical aspects of cancer. Med Clin North Am 1971; 55:525. [Entire issue.]Google Scholar
  15. Lawrence W Jr, Terz JJ (editors): Cancer Management. Grune & Stratton, 1977Google Scholar
  16. Moss WT, Brand WN, Battifora H: Radiation Oncology. Mosby, 1979Google Scholar
  17. Munster AM (editor): Surgical Immunology. Grune & Stratton. 1976Google Scholar
  18. Nealon TF Jr (editor): Management of the Patient With Cancer, 2nd ed. Saunders, 1976Google Scholar
  19. Noskell CM: Cancer Treatment. Saunders, 1980Google Scholar
  20. Salmon SE: Cancer chemotherapy. Chap 45, pp 477–513, in: Review of Medical Pharmacology, 7th ed. Lange, 1980Google Scholar
  21. Salmon SE, Jones SE (editors): Adjuvant Therapy of Cancer. Vol 3, Grune & Stratton, 1981Google Scholar
  22. Van Der Veer LD Jr, Balini JA: Chemotherapy of gastrointestinal malignancy. Am J Gastroenterol 1980; 74:40PubMedGoogle Scholar
  23. Veidenheimer MC (editor): Symposium on the care and treatment of the cancer patient. Surg Clin North Am 1967; 47:557Google Scholar

Ätiologische Faktoren bei der Tumorbildung

  1. Allen DW et al: Viruses and human cancer. N Engl J Med 1972; 286:70PubMedCrossRefGoogle Scholar
  2. American Cancer Society: Second National Conference on Diet, Nutrition, and Cancer. Cancer 1986; 59 (Suppl): 1791Google Scholar
  3. Bast RC Jr et al: BCG and cancer. (2 parts.) N Engl J Med 1974; 290:1413PubMedCrossRefGoogle Scholar
  4. Bootwell R: Tumor promoters in human carcinogenesis. Pages 16–27 in: Important Advances in Oncology 1985. De Vita VT, Hellman S, Rosenberg SA (editors). Lippincott, 1985Google Scholar
  5. Durack DT: Opportunistic infections and Kaposi’s sarcoma in homosexual men. (Editorial.) N Engl J Med 1981; 305:1465PubMedCrossRefGoogle Scholar
  6. Farber E: Chemical carcinogenesis. N Engl J Med 1981; 305:1379PubMedCrossRefGoogle Scholar
  7. Gallo RC: RNA-dependent DNA polymerase in viruses and cells. Blood 1972; 39:117PubMedGoogle Scholar
  8. Gofman JW, Tamplin AR: Radiation, cancer, and environmental health. Hosp Pract (Oct) 1970; 5:91Google Scholar
  9. Greenwald P, Ershow AG, Novelli WD (editors): Cancer Diet, and Nutrition: A Comprehensive Sourcebook. Who’s Who, Inc., 1985Google Scholar
  10. Grobstein C (editor): Diet, Nutrition and Cancer. National Academy Press, 1982Google Scholar
  11. Ryser HJP: Chemical carcinogenesis. N Engl J Med 1971; 285:721PubMedCrossRefGoogle Scholar
  12. Smith RT: Possibilities and problems of immunologic intervention in cancer. N Engl J Med 1972; 287:439PubMedCrossRefGoogle Scholar
  13. Zamcheck N et al: Immunologic evaluation of human digestive tract cancer: Carcinoembryonic antigens. N Engl J Med 1972; 286:83PubMedCrossRefGoogle Scholar

Aids

  1. Allen JR: Epidemiology of the acquired immunodeficiency syndrome (AIDS) in the United States. Semin Oncol 1984;11:4PubMedGoogle Scholar
  2. Gallo RC et al: T cell malignancies and human T cell leukemia virus. Semin Oncol 1984; 11:12PubMedGoogle Scholar
  3. Volberding P: Therapy of Kaposi’s sarcoma in AIDS. Semin Oncol 1984; 11:60PubMedGoogle Scholar

Onkogenese

  1. Gordon H: Oncogenes. Mayo Clin Proc 1985; 60:697PubMedGoogle Scholar
  2. Green AR, Wyke JA: Anti-oncogenes: A subset of regulatory genes involved in carcinogenesis? Lancet 1985; 2: 475PubMedCrossRefGoogle Scholar

Solitärmetastasen

  1. Adkins PC et al: Thoracotomy on the patient with previous malignancy: Metastasis of new primary? J Thorac Cardio-vasc Surg 1968; 56:361Google Scholar
  2. Rubin P, Green J: Solitary Metastases. Thomas, 1968Google Scholar

Immuntherapie

  1. Beutler B, Cerami A: Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986; 320:584PubMedCrossRefGoogle Scholar
  2. Gutterman JU et al: Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 1980; 93:399PubMedGoogle Scholar
  3. Lotze MT et al: Monoclonal antibody imaging of human melanoma: Radioimmunodetection by subcutaneous or systemic injection. Ann Surg 1986; 204:223PubMedCrossRefGoogle Scholar
  4. Munster AM (editor): Surgical Immunology. Grune & Stratton, 1976Google Scholar
  5. Pinsky CM et al: Biological response modifiers. Semin Oncol 1986; 13:131 [Entire issue]Google Scholar
  6. Rosenberg SA, Speiss P, La Freniere R: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233:1318PubMedCrossRefGoogle Scholar
  7. Rosenberg SA et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485PubMedCrossRefGoogle Scholar
  8. Smith RT: Possibilities and problems of immunologic intervention in cancer. N Engl J Med 1972; 287:437Google Scholar
  9. Terry WD (editor): Symposium on immunotherapy in malignant disease. Med Clin North Am 1976; 60:387. [Entire issue]Google Scholar
  10. Terry WD, Windhorst D (editors): Immunotherapy of Cancer: Present Status of Trials in Man. Vol 6 of: Progress in Cancer Research and Therapy. Raven Press, 1978. [Entire volume.]Google Scholar
  11. Vadhan-Raj S et al: Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol 1986; 4:137PubMedGoogle Scholar

Chemotherapie

  1. Alberts DS: In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 1980; 2:340PubMedCrossRefGoogle Scholar
  2. Bergevin PR, Tormey DC, Blom J: Guide to the use of cancer chemotherapeutic agents. Mod Treat 1972; 9:185PubMedGoogle Scholar
  3. Bergsagel DE: New perspectives in chemotherapy: Focus on Novantrone. Semin Oncol 1984; 11 (Suppl 1): 1. [Entire issue.]Google Scholar
  4. Borgmann V et al: Treatment of prostatic cancer with LH-RH analogues. Prostate 1983; 4:553PubMedCrossRefGoogle Scholar
  5. Bruce WR et al: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 1966; 37:233PubMedGoogle Scholar
  6. The choice of therapy in the treatment of malignancy. Med Lett Drugs Ther 1973; 15:9Google Scholar
  7. De Vita VT: Cell kinetics and the chemotherapy of cancer. Cancer Chemother Rep 1971; 2:23Google Scholar
  8. De Vita VT, Schein PS: The use of drugs in combination for the treatment of cancer. N Engl J Med 1973; 288:988Google Scholar
  9. Holland JF: Karnofsky Memorial Lecture: Breaking the cure barrier. J Clin Oncol 1983; 1:75PubMedGoogle Scholar
  10. Labrie F et al: New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens. Prostate 1983; 4:579PubMedCrossRefGoogle Scholar
  11. Livingston RB, Carter SK: Single Agents in Cancer Chemotherapy. Plenum Press, 1970Google Scholar
  12. Philips NC, Lauper RD: Review of etoposide. Clin Pharm 1983; 2:112Google Scholar
  13. Pinedo HM, Chabner BA (editors): Cancer Chemotherapy Annual. Elsevier, 1984Google Scholar
  14. Rall DP (chairman): Design of more selective antitumor agents. Cancer Res 1969; 29:2384Google Scholar
  15. Salmon SE (editor): Clinical correlation of drug sensitivity. Pages 265–285 in: Cloning of Human Tumor Stem-Cells. Liss, 1980Google Scholar
  16. Salmon SE et al: Quantitation of differential sensitivities of human-tumor stem-cells to anti-cancer drugs. N Engl J Med 1978; 298:1231CrossRefGoogle Scholar
  17. Santen RJ et al: Long-term effects of administration of a gonadotropin-releasing hormone superagonist along in men with prostatic carcinoma. J Clin Endocrinol Metab 1984; 58:397PubMedCrossRefGoogle Scholar
  18. Schabel FM: The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors. Cancer Res 1969; 29:2384Google Scholar
  19. Skipper HE et al: Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemother Rep 1970; 54:431PubMedGoogle Scholar
  20. Spiegel RJ: Intron A (interferon a-2b): Clinical overview and future directions. Semin Oncol 1986; 13 (Suppl 2): 89PubMedGoogle Scholar
  21. Valeriote FA, Edelstein MB: The role of cell kinetics in cancer chemotherapy. Semin Oncol 1977; 4:217PubMedGoogle Scholar

Adjuvante Chemotherapie

  1. Bonnadonna G et al: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976; 294:405CrossRefGoogle Scholar
  2. Fisher B et al: L-Phenylalanine mustard (l-PAM) in the management of primary breast cancer: A report of early findings. N Engl J Med 1975; 292:117PubMedCrossRefGoogle Scholar
  3. Fisher F et al: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 1968; 168:337PubMedCrossRefGoogle Scholar
  4. Jones SE, Salmon SE (editors): Adjuvant Therapy of Cancer II. Grune & Stratton, 1977Google Scholar
  5. Li MC et al: Chemoprophylaxis for patients with colorectal cancer. JAMA 1976; 235:2825Google Scholar
  6. Mackman S, Curreri AR, Ansfield FS: Second look operation for colon carcinoma after fluorouracil therapy. Arch Surg 1970; 100:527PubMedGoogle Scholar

Infusions- und Perfusionstherapie

  1. Ansfield FJ et al: Intrahepatic arterial infusion with 5-fluorouracil. Cancer 1971; 28:1147PubMedCrossRefGoogle Scholar
  2. Ensminger W et al: Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981; 65:393PubMedGoogle Scholar
  3. Freckman HA: Chemotherapy for metastatic colorectal liver carcinoma by intra-aortic infusion. Cancer 1971; 28:1152PubMedCrossRefGoogle Scholar
  4. Goldstein HM et al: Transcatheter occlusion of abdominal tumors. Radiology 1976; 120:539PubMedGoogle Scholar
  5. Krementz ET, Creech O Jr, Ryan RF: Evaluation of chemotherapy of cancer by regional perfusion. Cancer 1967; 20:834PubMedCrossRefGoogle Scholar

Chemotherapeutische Kombinationsbehandlung

  1. Carbone PP, Davis TE: Medical treatment for advanced breast cancer. Semin Oncol 1978; 5:417PubMedGoogle Scholar
  2. DeVita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 1970; 73:881PubMedGoogle Scholar
  3. DeVita VT Jr et al: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer 1975; 35:98PubMedCrossRefGoogle Scholar
  4. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87:293PubMedGoogle Scholar
  5. Greenspan EM: Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma. Mt Sinai J Med NY 1966; 33:1Google Scholar
  6. Li MC et al: Effects of combined drug therapy on metastatic cancer of the testis. JAMA 1960; 174:1291PubMedGoogle Scholar
  7. Luce JK: Chemotherapy for lymphomas: Current status. Page 295 in: Leukemia-Lymphoma. Year Book, 1969Google Scholar
  8. Samuels ML: Continuous intravenous bleomycin therapy with vinblastine in testicular and extragonadal germinal tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:112Google Scholar

Ungesicherte Behandlungsmethoden in der Krebstherapie

  1. Herbert V: Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment. Cancer 1986; 58 (8 Suppl): 1930PubMedCrossRefGoogle Scholar
  2. Moertel CG et al: A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982; 306:201 Diagnostisches Vorgehen bei Patienten mit unbekanntem PrimärtumorPubMedCrossRefGoogle Scholar
  3. Altman E, Cadman E: An analysis of 1539 patients with cancer of unknown primary site. Cancer 1986; 57:120PubMedCrossRefGoogle Scholar
  4. Brady LW et al: Unusual sites of metastases. Semin Oncol 1977; 4:59PubMedGoogle Scholar
  5. Didolkar MS et al: Metastatic carcinomas from occult primary tumors: A study of 254 patients. Ann Surg 1977; 186:625PubMedCrossRefGoogle Scholar
  6. Greco FA, Oldham RK, Fer MF: The extragonadal germ cell cancer syndrome. Semin Oncol 1982; 9:448PubMedGoogle Scholar
  7. Grosbach AB: Carcinoma of unknown primary site: A clinical enigma. Arch Intern Med 1982; 142:357PubMedCrossRefGoogle Scholar
  8. Karsell PR, Sheedy PF II, O’Connell MJ: Computed tomography in search of cancer of unknown origin. JAMA 1982; 248:340PubMedCrossRefGoogle Scholar
  9. Nystrom JS et al: Identifying the primary site in metastatic cancer of unknown origin: Inadequacy of roentgeno-graphic procedures. JAMA 1979; 241:381PubMedCrossRefGoogle Scholar
  10. Nystrom JS et al: Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 1977; 4:53PubMedGoogle Scholar
  11. Osteen RT, Kopf G, Wilson RE: In pursuit of the unknown primary. Am J Surg 1978; 135:494PubMedCrossRefGoogle Scholar
  12. Woods RL et al: Metastatic adenocarcinomas of unknown primary site: A randomized study of two combination-chemotherapy regimens. N Engl J Med 1980; 303:87PubMedCrossRefGoogle Scholar

Paraneoplastische Syndrome

  1. Hall TC (editor): Paraneoplastic syndromes. Ann NY Acad Sci 1974; 230:1. [Entire issue.]Google Scholar
  2. Waldenström JG: Paraneoplasia. Wiley, 1978Google Scholar

Neuroblastom

  1. Evans AE et al: A review of 17IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer 1980; 45:833PubMedCrossRefGoogle Scholar

Nierenzellkarzinom

  1. Bloom HJG: Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973; 32:1066PubMedCrossRefGoogle Scholar
  2. Klippel KF, Altwein JE: Palliative Therapiemöglichkeiten beim metastasierten Hypernephrom. Dtsch Med Wo-chenschr 1979; 104:28CrossRefGoogle Scholar
  3. Krown SE: Therapeutic options in renal-cell carcinoma. Semin Oncol 1985; 12 (Suppl 5): 13PubMedGoogle Scholar
  4. Lokich JJ, Harrison JH: Renal cell carcinoma: Natural history and chemotherapeutic experience. J Urol 1975; 114:371PubMedGoogle Scholar
  5. Talley RW: Proceedings: Chemotherapy of adenocarcinoma of the kidney. Cancer 1973; 32:1062PubMedCrossRefGoogle Scholar

Wilms-Tumor

  1. Green DM, Jaffe N: Wilms’ tumor: Model of a curable pediatric malignant solid tumor. Cancer Treat Rev (Sept) 1978; 5:143CrossRefGoogle Scholar

Übergangszellkarzinom

  1. Carter SK: Chemotherapy and genitourinary oncology. 1. Bladder cancer. Cancer Treat Rev (June) 1978; 5:85CrossRefGoogle Scholar
  2. Hahn RG: Bladder cancer treatment considerations for metastatic disease. Semin Oncol 1979; 6:236PubMedGoogle Scholar
  3. Koontz WW Jr: Intravesical chemotherapy and chemopre-vention of superficial, low grade, low stage bladder carcinoma. Semin Oncol 1979; 6:217PubMedGoogle Scholar

Prostatakarzinom

  1. Mittelman A, Shukla SK, Murphy GP: Extended therapy of stage D carcinoma of the prostate with oral estramus-tine phosphate. J Urol 1976; 115:409PubMedGoogle Scholar
  2. Torti FM, Carter SK: The chemotherapy of prostatic adenocarcinoma. Ann Intern Med 1980; 92:681PubMedGoogle Scholar

Hodenkarzinom

  1. Cvitkovic E et al: Bleomycin (BLEO) infusion with cis-platinum diammine dichloride (CPDD) as secondary chemotherapy for germinal cell tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:273Google Scholar
  2. Einhorn LH, Donohue JP: Combination chemotherapy in disseminated testicular cancer. Semin Oncol 1979; 6:87PubMedGoogle Scholar
  3. Einhorn LH, Furnas BE, Powell N: Combination chemotherapy of disseminated testicular carcinoma with cis-platinum diammine chloride (CPDD), vinblastine (VLB), and bleomycin (BLEO). (Abstract.) Proc Am Assoc Cancer Res 1976; 17:240Google Scholar
  4. Friedman M, Purkayastha MC: Recurrent seminoma: The management of late metastasis, recurrence, or a second primary tumor. Am J Roentgenol 1960; 83:25Google Scholar
  5. Golbey RB, Reynolds TF, Vugrin D: The chemotherapy of metastatic germ cell tumors. Semin Oncol 1979; 6:82PubMedGoogle Scholar
  6. Javadpour N: The value of biologic markers in the diagnosis and treatment of testicular carcinoma. Semin Oncol 1979; 6:37PubMedGoogle Scholar
  7. Li MC et al: Effects of combined drug therapy on metastatic cancer of the testis. JAMA 1960; 174:1291PubMedGoogle Scholar
  8. Samuels ML: Continuous intravenous bleomycin therapy with vinblastine in testicular and extragonadal germinal tumors. (Abstract.) Proc Am Assoc Cancer Res 1975; 16:112Google Scholar
  9. Williams SD, Einhorn LH: Etoposide salvage therapy for refractory germ cell tumors: An update. Cancer Treat Rev 1982; 9 (Suppl A):67PubMedCrossRefGoogle Scholar

Schmerztherapie bei Krebs

  1. Brechner VL, Ferrer-Brechner T, Allen GD: Anaesthetic measures in management of pain associated with malignancy. Semin Oncol 1977; 4:99PubMedGoogle Scholar
  2. Catalano RB: The medical approach to management of pain caused by cancer. Semin Oncol 1975; 2:379PubMedGoogle Scholar

Therapie des Erbrechens bei Chemotherapie

  1. Frytak S, Moertel CG: Management of nausea and vomiting in the cancer patient. JAMA 1981; 245:393PubMedCrossRefGoogle Scholar
  2. Frytak S et al: Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A comparison with prochlorperazine and a placebo. Ann Intern Med 1979; 91:825PubMedGoogle Scholar
  3. Gralla RJ et al: Antiemetic efficacy of high-dose meto-clopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305:905PubMedCrossRefGoogle Scholar
  4. Siegel LJ, Longo DL: The control of chemotherapy-induced emesis. Ann Intern Med 1981; 95:352Google Scholar

Bakterielle Sepsis bei Tumorpatienten

  1. Alavi JB et al: Randomized clinical trial of granulocyte transfusions and infection in acute leukemia. N Engl J Med 1977; 296:706PubMedCrossRefGoogle Scholar
  2. Dilworth JA, Mandell GL: Infections in patients with cancer. Semin Oncol 1975; 2:349PubMedGoogle Scholar
  3. Herzig R et al: Successful granulocyte transfusion therapy for gram-negative septicemia: A prospectively randomized controlled study. N Engl J Med 1977; 296:701PubMedCrossRefGoogle Scholar
  4. Ketchel SJ, Rodriguez V: Acute infections in cancer patients. Semin Oncol 1978; 5:167PubMedGoogle Scholar
  5. Wiernik PH: The management of infection in the cancer patient. JAMA 1980; 244:185PubMedCrossRefGoogle Scholar

Behandlung von Extravasaten durch Vesikanzien

  1. Blacklock HA et al: Use of modified subcutaneous right-atrial catheter for venous access in leukaemic patients. Lancet 1980; 1:993PubMedCrossRefGoogle Scholar
  2. Larson DL: Treatment of tissue extravasation by antitumor agents. Cancer 1982; 49:1796PubMedCrossRefGoogle Scholar

Behandlung, lokaler Tumorkomplikationen

  1. Davenport D et al: Radiation therapy in the treatment of superior vena caval obstruction. Cancer 1978; 42:2600Google Scholar
  2. Lambert CJ: Treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg 1967; 3:1PubMedCrossRefGoogle Scholar
  3. Lenhard RE Jr (editor): Clinical case records in chemotherapy: The management of hypercalcemia complicating cancer. Cancer Chemother Rep 1971; 55:509PubMedGoogle Scholar
  4. Levitt SH et al: Treatment of malignant superior vena caval obstruction. Cancer 1969; 24:447PubMedCrossRefGoogle Scholar
  5. Millburn L, Hibbs GG, Hendrickson FR: Treatment of spinal cord compression from metastatic carcinoma. Cancer 1968; 21:447PubMedCrossRefGoogle Scholar
  6. Perez CA, Bradfield JS, Morgan HC: Management of pathologic fractures. Cancer 1972; 29:684PubMedCrossRefGoogle Scholar
  7. Rubin P et al: Superior vena caval syndrome: Slow low dose versus rapid high dose schedule. Radiology 1963; 81:388PubMedGoogle Scholar

Ernährungsbehandlung von Tumorpatienten

  1. Copeland EM, Dudrick SJ: Cancer: Nutritional concepts. Semin Oncol 1975; 2:329PubMedGoogle Scholar
  2. DeWys WD: Nutritional care of the cancer patient. JAMA 1980; 244:374PubMedCrossRefGoogle Scholar

Psychologische Betreuung von Tumorpatienten

  1. Dunphy JE: Caring for the patient with cancer. N Engl J Med 1976; 295:313PubMedCrossRefGoogle Scholar

Häusliche Betreuung von Patienten mit fortgeschrittener Krebserkrankung

  1. Rosenbaum EH: Principles of home care for the patient with advanced cancer. JAMA 1980; 244:1484PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • D. E. Johnson
  • D. A. Swanson
  • A. C. von Eschenbach

There are no affiliations available

Personalised recommendations